Results 161 to 170 of about 6,044,633 (290)

Why medical humanities?

Research and Humanities in Medical Education, 2014
Upreet Dhaliwal
doaj  

Humanities in medical education

International Journal of Applied and Basic Medical Research, 2020
openaire   +2 more sources

An agenda for the medical humanities and ageing. [PDF]

Hist Human Sci
Zimmermann M.
europepmc   +1 more source

Medical College building, 1914

, 1914
This glass lantern slide features a ground view of the Medical College Building of the Medical College of the State of South Carolina in ...
Medical College of South Carolina (1952-1969). Department of Medical Illustration
core  

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Medical humanities in medical schools in India

Archives of Medicine and Health Sciences, 2016
Pathiyil Ravi Shankar
doaj   +1 more source

Beyond Evaluation: Resisting Quantification in the Medical Humanities. [PDF]

ATS Sch
Helmers A, Healy L, Mema B.
europepmc   +1 more source

Does medical humanities matter? The challenge of COVID-19. [PDF]

Med Humanit, 2023
Macnaughton J.
europepmc   +1 more source

Medical Center, 1951 status

, 1951
This glass lantern slide features an aerial view of the Medical Center campus of the Medical College of South Carolina in ...
Medical College of South Carolina (1952-1969). Department of Medical Illustration
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source